The global guillain barre syndrome treatment market is anticipated to grow at a significant CAGR of 5.2% during the forecast period 2022-2028. The increasing infections caused by the Epstein–Barr virus, zika virus, and other viruses, as a result of the increased need for treatment. For instance, in 2019, according to the Foundation for Peripheral Neuropathy […]